Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease.

@article{Brown2016DigoxinUI,
  title={Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease.},
  author={David W. Brown and Colleen Mangeot and Jeffrey B. Anderson and Laura E Peterson and Eileen C. King and Stacey L Lihn and Steven R. Neish and Craig E Fleishman and Christina Marie Phelps and Samuel P. Hanke and Robert H. Beekman and Carole Lannon},
  journal={Journal of the American Heart Association},
  year={2016},
  volume={5 1}
}
BACKGROUND Interstage mortality (IM) remains significant after stage 1 palliation (S1P) for single-ventricle heart disease (SVD), with many deaths sudden and unexpected. We sought to determine whether digoxin use post-S1P is associated with reduced IM, utilizing the multicenter database of the National Pediatric Cardiology Quality Improvement Collaborative… CONTINUE READING